Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal dysfunction as a cardiovascular risk factor.

Eberhard Ritz1, Ralf Dikow, Luis M Ruilope

  • 1Department of Internal Medicine, University of Heidelberg, Bergheimer Strasse 58, Germany. Prof.E.Ritz@t-online.de

Current Hypertension Reports
|September 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria.

Kidney & blood pressure research·2018
Same author

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Clinical and experimental nephrology·2017
Same author

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Clinical kidney journal·2016
Same author

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

BMC nephrology·2016
Same author

Bariatric surgery and the kidney-much benefit, but also potential harm.

Clinical kidney journal·2016
Same author

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Journal of hypertension·2016
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

Altered kidney function, indicated by microalbuminuria or proteinuria, predicts cardiovascular disease. Early treatment of hypertension in at-risk patients is crucial for preventing kidney damage and cardiovascular events.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Altered renal function indices, including microalbuminuria, elevated serum creatinine, and decreased creatinine clearance, are established independent predictors of cardiovascular morbidity and mortality.
  • These renal function parameters warrant routine evaluation in elderly individuals and those at high cardiovascular risk, especially if hypertension is present.

Purpose of the Study:

  • To emphasize the importance of evaluating renal function in predicting cardiovascular outcomes.
  • To advocate for the prevention of hypertensive kidney damage through early, aggressive treatment in patients with microalbuminuria.
  • To recommend antihypertensive agents with minimal metabolic side effects to mitigate cardiovascular risk.

Main Methods:

  • Review of epidemiological data linking renal and cardiovascular outcomes.

Related Experiment Videos

  • Analysis of established predictors of cardiovascular morbidity and mortality.
  • Clinical guidelines for managing hypertension and renal function.

    • Main Results:

    • Indices of renal dysfunction are significant independent predictors of cardiovascular morbidity and mortality.
    • Routine assessment of renal function is recommended for elderly and high-cardiovascular-risk populations, particularly those with hypertension.
    • Early and aggressive treatment of hypertensive patients with microalbuminuria can prevent kidney damage.

    Conclusions:

    • Renal and cardiovascular outcomes are closely linked in high-risk populations.
    • Preventive strategies targeting renal function are essential for reducing overall cardiovascular risk.
    • Careful selection of antihypertensive agents is necessary to avoid adverse metabolic effects and protect renal function.